387215006: Phenyltoloxamine (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Histamine receptor antagonist\Ethanolamine derivative antihistamine\Phenyltoloxamine (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amine and/or amine derivative\Ethanolamine and/or ethanolamine derivative (substance)\Ethanolamine derivative antihistamine\Phenyltoloxamine (substance)

\Organic compound\Organic nitrogen compound\Amine and/or amine derivative\Ethanolamine and/or ethanolamine derivative (substance)\Ethanolamine derivative antihistamine\Phenyltoloxamine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1461393010 Phenyltoloxamine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1481318014 Phenyltoloxamine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

26161000188115 phényltoloxamine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Phenyltoloxamine (substance)	Is a	Ethanolamine derivative antihistamine	true	Inferred relationship	Some
Phenyltoloxamine (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Histamine receptor antagonist (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Phenyltoloxamine measurement (procedure)	Component	True	Phenyltoloxamine (substance)	Inferred relationship	Some	1
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 4mg/20mg/50mg m/r capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenyltoloxamine (substance)	Inferred relationship	Some
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 2.5mg/5mL 5mg/5mL 7.5mg/5mL liquid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenyltoloxamine (substance)	Inferred relationship	Some
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenyltoloxamine (substance)	Inferred relationship	Some
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenyltoloxamine (substance)	Inferred relationship	Some
Acetaminophen + phenyltoloxamine citrate 500mg/30mg caplets	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenyltoloxamine (substance)	Inferred relationship	Some
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenyltoloxamine (substance)	Inferred relationship	Some
Paracetamol 500 mg and phenyltoloxamine citrate 60 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenyltoloxamine (substance)	Inferred relationship	Some
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenyltoloxamine (substance)	Inferred relationship	Some
Product containing phenyltoloxamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenyltoloxamine (substance)	Inferred relationship	Some	1
Product containing precisely chlorphenamine maleate 4 milligram and mepyramine maleate 25 milligram and phenylephrine hydrochloride 10 milligram and phenylpropanolamine 50 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenyltoloxamine (substance)	Inferred relationship	Some
Product containing paracetamol and phenyltoloxamine citrate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenyltoloxamine (substance)	Inferred relationship	Some
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenyltoloxamine (substance)	Inferred relationship	Some
Product containing paracetamol and phenyltoloxamine citrate and salicylamide	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenyltoloxamine (substance)	Inferred relationship	Some
Product containing magnesium salicylate and phenyltoloxamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenyltoloxamine (substance)	Inferred relationship	Some	1
Phenyltoloxamine citrate	Is a	False	Phenyltoloxamine (substance)	Inferred relationship	Some
Phenyltoloxamine citrate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Phenyltoloxamine (substance)	Inferred relationship	Some
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 4mg/20mg/50mg prolonged-release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenyltoloxamine (substance)	Inferred relationship	Some
Product containing paracetamol and phenyltoloxamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenyltoloxamine (substance)	Inferred relationship	Some	1
Product containing paracetamol and phenyltoloxamine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenyltoloxamine (substance)	Inferred relationship	Some	1
Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenyltoloxamine (substance)	Inferred relationship	Some	2
Product containing paracetamol and phenyltoloxamine and salicylamide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenyltoloxamine (substance)	Inferred relationship	Some	2
Product containing only magnesium salicylate and phenyltoloxamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenyltoloxamine (substance)	Inferred relationship	Some	1
Phenyltoloxamine only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenyltoloxamine (substance)	Inferred relationship	Some	1
Product containing only paracetamol and phenyltoloxamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenyltoloxamine (substance)	Inferred relationship	Some	1
Paracetamol and phenyltoloxamine and salicylamide only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenyltoloxamine (substance)	Inferred relationship	Some	2
Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenyltoloxamine (substance)	Inferred relationship	Some	2
Product containing only paracetamol and phenyltoloxamine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenyltoloxamine (substance)	Inferred relationship	Some	1
Chlorphenamine and phenylephrine and phenyltoloxamine only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenyltoloxamine (substance)	Inferred relationship	Some	3
Chlorphenamine and phenylephrine and phenyltoloxamine only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenyltoloxamine (substance)	Inferred relationship	Some	3
Product containing chlorphenamine and phenylephrine and phenyltoloxamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenyltoloxamine (substance)	Inferred relationship	Some	3
Product containing chlorphenamine and phenylephrine and phenyltoloxamine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenyltoloxamine (substance)	Inferred relationship	Some	3

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461393010	Phenyltoloxamine (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481318014	Phenyltoloxamine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
26161000188115	phényltoloxamine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module